2022
Novo Holdings acquires The Ritedose Corporation and fully automated packaging lines increased to six
Stability & Regulatory Support
ICH Stability program to support semipermeable conditions. Regulatory team supports project throughout regulatory lifecycle.
Analytical & Microbiology Support
Dedicated multidisciplinary team to support all aspects of development from method development, method validation, sterility & bioburden along with our robust microbiology lab.
Process Development & Technology Transfer
Development engineering teams lead all aspects of product development/transfers from the clinical study stage and manage projects throughout the development lifecycle, process validation & commercial launch.
2016
TRC obtains fourth ANDA and operating capacity reaches 2.1 billion units with 10 BFS machines, five fully automated packaging lines and one semi-automated packaging line
- 1
- 2
Recent Posts
- Ritedose Pharmaceuticals Receives FDA Approval for Generic Formoterol Fumarate Inhalation Treatment for Respiratory Illness
- Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre
- Ritedose Expands Commitment to Service with 1,000 Hours of Purpose Initiative
- Ritedose and Newberry College Forge Strategic Partnership to Launch Pharmaceutical Manufacturing Program
- Ritedose Meets Workforce Demand with RISE Program Partnership with InSpring and Benedict College
Archives
- May 2025
- April 2025
- March 2025
- January 2025
- October 2024
- September 2024
- August 2024
- July 2024
- February 2024
- August 2023
- May 2023
- April 2023
- January 2023
- November 2022
- October 2022
- February 2022
- January 2022
- December 2021
- September 2021
- August 2021
- May 2021
- April 2021
- March 2021
- November 2020
- August 2020
- March 2020
Categories
Recent News
-
-
-
Ritedose Expands Commitment to Service with 1,000 Hours of Purpose Initiative Posted on 5th March, 2025
Post Tags
Post Categories
- Careers (2)
- CDMO (6)
- Community (12)
- Generics (5)
- In the News (7)
- News (22)
- Press Releases (7)
- Uncategorized (10)
Recent Comments